PK11195 effect on steroidogenesis is not mediated through the translocator protein (TSPO)

Endocrinology (United States)

Volumn 156, Issue 3, 2015, Pages 1033-1039

  Tu, Lan N ^a   Zhao, Amy H ^a   Stocco, Douglas M ^b   Selvaraj, Vimal ^a,c  

^a Program on Infrastructure Policy   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; MESSENGER RNA; MITOCHONDRIAL PROTEIN; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; OUTER MEMBRANE PROTEIN; PROGESTERONE; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; ANTINEOPLASTIC AGENT; BZRP PROTEIN, MOUSE; ISOQUINOLINE DERIVATIVE;

ALLELE; ALPHA HELIX; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CRISPR CAS SYSTEM; DNA END JOINING REPAIR; DOSE RESPONSE; DOUBLE STRANDED DNA BREAK; EXON; GENE DELETION; LEYDIG CELL TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; START CODON; STEROIDOGENESIS; ANIMAL; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE DELETION; ISOQUINOLINES; LEYDIG CELL TUMOR; MICE; RECEPTORS, GABA;

EID: 84923870787     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1707     Document Type: Article

References (38)

1. Yeliseev AA, Kaplan S. A sensory transducer homologous to the mammalian peripheral-type benzodiazepine receptor regulates photosynthetic membrane complex formation in Rhodobacter sphaeroides 2.4.1. J Biol Chem. 1995;270:21167-21175.
2. Braestrup C, Squires RF. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci U S A. 1977;74:3805-3809.
3. Braestrup C, Albrechtsen R, Squires RF. High densities of benzodiazepine receptors in human cortical areas. Nature. 1977;269:702-704.
4. Regan JW, Yamamura HI, Yamada S, Roeske WR. High affinity [3H]flunitrazepam binding: Characterization, localization, and alteration in hypertension. Life Sci. 1981;28:991-998.
5. Davies LP, Huston V. Peripheral benzodiazepine binding sites in heart and their interaction with dipyridamole. Eur J Pharmacol. 1981;73:209-211.
6. Le Fur G, Perrier ML, Vaucher N, et al. Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. Life Sci. 1983;32:1839-1847.
7. Gavish M, Bachman I, Shoukrun R, et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev. 1999;51:629-650.
8. Anholt RR, DeSouza EB, Oster-Granite ML, Snyder SH. Peripheraltype benzodiazepine receptors: Autoradiographic localization in whole-body sections of neonatal rats. J Pharmacol Exp Ther. 1985;233:517-526.
9. Wang HJ, Fan J, Papadopoulos V. Translocator protein (Tspo) gene promoter-driven green fluorescent protein synthesis in transgenic mice: An in vivo model to study Tspo transcription. Cell Tissue Res. 2012;350:261-275.
10. Morohaku K, Phuong NS, Selvaraj V. Developmental expression of translocator protein/peripheral benzodiazepine receptor in reproductive tissues. PloS One. 2013;8:e74509.
11. Anholt RR, Pedersen PL, De Souza EB, Snyder SH. The peripheraltype benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem. 1986;261:576-583.
12. Li H, Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology. 1998;139:4991-4997.
13. Jaremko L, Jaremko M, Giller K, Becker S, Zweckstetter M. Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science. 2014;343:1363-1366.
14. Murail S, Robert JC, Coïc YM, et al. Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding. Biochim Biophys Acta. 2008;1778:1375-1381.
15. Korkhov VM, Sachse C, Short JM, Tate CG. Three-dimensional structure of TspO by electron cryomicroscopy of helical crystals. Structure. 2010;18:677-687.
16. Midzak A, Rone M, Aghazadeh Y, Culty M, Papadopoulos V. Mitochondrial protein import and the genesis of steroidogenic mitochondria. Mol Cell Endocrinol. 2011;336:70-79.
17. Mukhin AG, Papadopoulos V, Costa E, Krueger KE. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc Natl Acad Sci U S A. 1989;86:9813-9816.
18. Papadopoulos V, Mukhin AG, Costa E, Krueger KE. The peripheraltype benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J Biol Chem. 1990;265:3772-3779.
19. Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem. 1994;269:28314-28322.
20. Caron KM, Soo SC, Wetsel WC, Stocco DM, Clark BJ, Parker KL. Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc Natl Acad Sci U S A. 1997;94:11540-11545.
21. Papadopoulos V, Amri H, Li H, Boujrad N, Vidic B, Garnier M. Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in theR2CLeydig tumor cell line. J Biol Chem. 1997;272:32129-32135.
22. Morohaku K, Pelton SH, Daugherty DJ, Butler WR, Deng W, Selvaraj V. Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology. 2014;155:89-97.
23. Papadopoulos V, Amri H, Boujrad N, et al. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids. 1997;62:21-28.
24. Tu LN, Morohaku K, Manna PR, et al. Peripheral Benzodiazepine Receptor/Translocator Protein Global Knock-out Mice Are Viable with No Effects on Steroid Hormone Biosynthesis. J Biol Chem. 2014;289:27444-27454.
25. Chung JY, Chen H, Midzak A, Burnett AL, Papadopoulos V, Zirkin BR. Drug ligand-induced activation of translocator protein (TSPO) stimulates steroid production by aged brown Norway rat Leydig cells. Endocrinology. 2013;154:2156-2165.
26. Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339:819-823.
27. Manna PR, Cohen-Tannoudji J, Counis R, et al. Mechanisms of action of hormone-sensitive lipase in mouse Leydig cells: Its role in the regulation of the steroidogenic acute regulatory protein. J Biol Chem. 2013;288:8505-8518.
28. Stocco DM. The Role of PBR/TSPO in Steroid Biosynthesis Challenged. Endocrinology. 2014;155:6-9.
29. Banati RB, Middleton RJ, Chan R, et al. Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. Nat Commun. 2014;5:5452.
30. Papadopoulos V. On the Role of the Translocator Protein (18-kDa) TSPO in Steroid Hormone Biosynthesis. Endocrinology. 2014;155:15-20.
31. Gocze PM, Freeman DA. Factors underlying the variability of lipid droplet fluorescence in MA-10 Leydig tumor cells. Cytometry. 1994;17:151-158.
32. Hatty CR, Le Brun AP, Lake V, et al. Investigating the interactions of the 18kDa translocator protein and its ligand PK11195 in planar lipid bilayers. Biochim Biophys Acta. 2014;1838:1019-1030.
33. Falchi AM, Battetta B, Sanna F, et al. Intracellular cholesterol changes induced by translocator protein (18 kDa) TSPO/PBR ligands. Neuropharmacology. 2007;53:318-329.
34. Seneviratne MS, Faccenda D, De Biase V, Campanella M. PK11195 inhibits mitophagy targeting the F1Fo-ATPsynthase in Bcl-2 knockdown cells. Curr Mol Med. 2012;12:476-482.
35. Gonzalez-Polo RA, Carvalho G, Braun T, et al. PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor. Oncogene. 2005;24:7503-7513.
36. Hans G, Wislet-Gendebien S, Lallemend F, et al. Peripheral benzodiazepine receptor (PBR) ligand cytotoxicity unrelated to PBR expression. Biochem Pharmacol. 2005;69:819-830.
37. Walter RB, Pirga JL, Cronk MR, Mayer S, Appelbaum FR, Banker DE. PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism. Blood. 2005;106:3584-3593.
38. Kletsas D, Li W, Han Z, Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) and PBR drug ligands in fibroblast and fibrosarcoma cell proliferation: Role of ERK, c-Jun and ligand-activated PBR-independent pathways. Biochem Pharmacol. 2004;67:1927-1932.